Nano-composite hydrogels of Cu-Apa micelles for anti-vasculogenic mimicry

References

• Kerbel RS. Tumor angiogenesis: past, present and the near future. Carcinogenesis. 2000;21(3):505–515.
   PubMed Web of Science ®Google Scholar
• Fathi Maroufi N, Taefehshokr S, Rashidi M-R, et al. Vascular mimicry: changing the therapeutic paradigms in cancer. Mol Biol Rep. 2020;47(6):4749–4765.
   PubMed Web of Science ®Google Scholar
• Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155(3):739–752.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Nong L, Chen M, et al. Baicalein suppresses vasculogenic mimicry through inhibiting RhoA/ROCK expression in lung cancer A549 cell line. Acta Biochim Biophys Sin (Shanghai). 2020;52(9):1007–1015.
   PubMed Web of Science ®Google Scholar
• Hendrix MJ, Seftor EA, Hess AR, et al. Molecular plasticity of human melanoma cells. Oncogene. 2003;22(20):3070–3075.
   PubMed Web of Science ®Google Scholar
• Hendrix MJ, Seftor EA, Seftor RE, et al. Tumor cell vascular mimicry: novel targeting opportunity in melanoma. Pharmacol Ther. 2016;159:83–92.
   PubMed Web of Science ®Google Scholar
• Frenkel S, Barzel I, Levy J, et al. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography. Eye (Lond). 2008;22(7):948–952.
   PubMed Web of Science ®Google Scholar
• Hu X, Cao J, Hu W, et al. Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer. BMC Cancer. 2014;14(1):820–828.
   PubMedGoogle Scholar
• Li J, Wang L. Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma. Onco Targets Ther. 2017;10:3965–3969.
   PubMed Web of Science ®Google Scholar
• Li J, Qin S, Xu J, et al. Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction. J Clin Oncol. 2016;34(13):1448–1454.
   PubMed Web of Science ®Google Scholar
• Roodhart JM, Langenberg MH, Witteveen E, et al. The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathway. Curr Clin Pharmacol. 2008;3(2):132–143.
   PubMedGoogle Scholar
• Schellhaas E, Loddenkemper C, Schmittel A, et al. Bowel perforation in non-small cell lung cancer after bevacizumab therapy. Invest New Drugs. 2009;27(2):184–187.
   PubMed Web of Science ®Google Scholar
• Scappaticci FA, Fehrenbacher L, Cartwright T, et al. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol. 2005;91(3):173–180.
   PubMed Web of Science ®Google Scholar
• Zhao D, Hou H, Zhang X. Progress in the treatment of solid tumors with apatinib: a systematic review. Onco Targets Ther. 2018;11:4137–4147.
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6(4):273–286.
   PubMed Web of Science ®Google Scholar
• Hsu JY, Wakelee HA. Monoclonal antibodies targeting vascular endothelial growth factor. BioDrugs. 2009;23(5):289–304.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Boggon TJ, Dayaram T, et al. EGFR mutation and resistance of non–small-cell lung cancer to gefitinib. N Engl J Med. 2005;352(8):786–792.
   PubMed Web of Science ®Google Scholar
• Wu YL, Zhou C, Hu CP, et al. Afatinib versus cisplatin plus gemcitabine for first-line treatment of asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial. Lee. Lancet Oncol. 2014;15(2):213–222.
   PubMed Web of Science ®Google Scholar
• Zhao B, Wu M, Hu Z, et al. Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation. Signal Transduct Tar. 2020;5(1):1–12.
   PubMed Web of Science ®Google Scholar
• Magrì A, Grasso G, Corti F, et al. Peptides derived from the histidine–proline rich glycoprotein bind copper ions and exhibit anti-angiogenic properties. Dalton Trans. 2018;47(28):9492–9503.
   PubMed Web of Science ®Google Scholar
• Li B, Jiang Z, Xie D, et al. Cetuximab-modified CuS nanoparticles integrating near-infrared-II-responsive photothermal therapy and anti-vessel treatment. Int J Nanomed. 2018;13:7289–7302.
   PubMed Web of Science ®Google Scholar
• Nagababu P, Barui AK, Thulasiram B, et al. Antiangiogenic activity of mononuclear copper (II) polypyridyl complexes for the treatment of cancers. J Med Chem. 2015;58(13):5226–5241.
   PubMed Web of Science ®Google Scholar
• Begum AB, Rekha N, Kumar BV, et al. Synthesis, characterization, biological and catalytic applications of transition metal complexes derived from schiff base. Bioorg Med Chem Lett. 2014;24(15):3559–3564.
   PubMed Web of Science ®Google Scholar
• Barenholz Y. Liposome application: problems and prospects. Curr Opin Colloid Interface Sci. 2001;6(1):66–77.
   Web of Science ®Google Scholar
• Jin M, Zhao K, Huang Q, et al. Structural features and biological activities of the polysaccharides from astragalus membranaceus. Int J Biol Macromol. 2014;64:257–266.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhong Y, Liang J, et al. Effect of astragalus polysaccharide on the expression of VEGF and EGFR in mice with lewis transplantable lung cancer. J Coll Physicians Surg Pak. 2019;29(4):392–394.
   PubMed Web of Science ®Google Scholar
• Owen SC, Chan DP, Shoichet MS. Polymeric micelle stability. Nano Today. 2012;7(1):53–65.
   Web of Science ®Google Scholar
• Liu Y, Sun J, Zhang P, et al. Amphiphilic polysaccharide-hydrophobicized graft polymeric micelles for drug delivery nanosystems. Curr Med Chem. 2011;18(17):2638–2648.
   PubMed Web of Science ®Google Scholar
• Akima K, Ito H, Iwata Y, et al. Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity. J Drug Target. 1996;4(1):1–8.
   PubMed Web of Science ®Google Scholar
• Deng C, Zhang Q, Fu Y, et al. Coadministration of oligomeric hyaluronic acid-modified liposomes with tumor-penetrating peptide-iRGD enhances the antitumor efficacy of doxorubicin against melanoma. ACS Appl Mater Interfaces. 2017;9(2):1280–1292.
   PubMed Web of Science ®Google Scholar
• Lammers T, Kiessling F, Hennink WE, et al. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release. 2012;161(2):175–187.
   PubMed Web of Science ®Google Scholar
• Amorim S, da Costa DS, Freitas D, et al. Molecular weight of surface immobilized hyaluronic acid influences CD44-mediated binding of gastric cancer cells. Sci Rep. 2018;8(1):1–11.
   PubMedGoogle Scholar
• Perschl A, Lesley J, English N, et al. Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol. 1995;25(2):495–501.
   PubMed Web of Science ®Google Scholar
• Ghatak S, Misra S, Toole BP. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/akt cell survival pathway. J Biol Chem. 2002;277(41):38013–38020.
   PubMed Web of Science ®Google Scholar
• Toole BP, Ghatak S, Misra S. Hyaluronan oligosaccharides as a potential anticancer therapeutic. Curr Pharm Biotechnol. 2008;9(4):249–252.
   PubMed Web of Science ®Google Scholar
• Zhao P, Damerow MS, Stern P, et al. CD44 promotes kras-dependent lung adenocarcinoma. Oncogene. 2013;32(43):5186–5190.
   PubMed Web of Science ®Google Scholar
• Serafino A, Zonfrillo M, Andreola F, et al. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis. Curr Cancer Drug Targets. 2011;11(5):572–585.
   PubMed Web of Science ®Google Scholar
• Wolszczak M, Miller J. Characterization of non-ionic surfactant aggregates by fluorometric techniques. J Photochem Photobiol. 2002;147(1):45–54.
   Web of Science ®Google Scholar
• Kim KH, Lee JC, Lee J. Amphiphilic Comb-Like polymers based on poly(oxyethylene)s as Drug-Delivery carriers. Macromol Biosci. 2008;8(4):339–346.
   PubMed Web of Science ®Google Scholar
• Yan S, Wang T, Feng L, et al. Injectable in situ self-cross-linking hydrogels based on poly(L-glutamic acid) and alginate for cartilage tissue engineering. Biomacromolecules. 2014;15(12):4495–4508.
   PubMed Web of Science ®Google Scholar
• Vartanian A, Stepanova E, Grigorieva I, et al. Melanoma vasculogenic mimicry capillary-like structure formation depends on integrin and calcium signaling. Microcirculation. 2011;18(5):390–399.
   PubMed Web of Science ®Google Scholar
• Xia Y, Cai XY, Fan JQ, et al. Rho kinase inhibitor fasudil suppresses the vasculogenic mimicry of B16 mouse melanoma cells both in vitro and in vivo. Mol Cancer Ther. 2015;14(7):1582–1590.
   PubMed Web of Science ®Google Scholar
• Zhao L, Du J, Duan Y, et al. Curcumin loaded mixed micelles composed of pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces. 2012;97:101–108.
   PubMed Web of Science ®Google Scholar
• Saadat E, Amini M, Dinarvand R, et al. Polymeric micelles based on hyaluronic acid and phospholipids: design, characterization, and cytotoxicity. J Appl Polym Sci. 2014;131(20):40944.
   Web of Science ®Google Scholar
• Mohammed A, Weston N, Coombes A, et al. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm. 2004;285(1–2):23–34.
   PubMed Web of Science ®Google Scholar
• Yang T, Lan Y, Cao M, et al. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer. Colloids Surf B Biointerfaces. 2019;175:106–115.
   PubMed Web of Science ®Google Scholar
• Miller T, Breyer S, Van Colen G, et al. Premature drug release of polymeric micelles and its effects on tumor targeting. Int J Pharm. 2013;445(1–2):117–124.
   PubMedGoogle Scholar
• Cheng Y, Yu S, Wang J, et al. In vitro and in vivo antitumor activity of doxorubicin-loaded alginic-acid-based nanoparticles. Macromol Biosci. 2012;12(10):1326–1335.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Nagasaki Y, Kato Y, et al. Long-circulating poly(ethylene glycol)-poly(d, l-lactide) block copolymer micelles with modulated surface charge. J Control Release. 2001;77(1–2):27–38.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li Y, Chen K, et al. Dual receptor-targeted and redox-sensitive polymeric micelles self-assembled from a folic acid-hyaluronic acid-SS-vitamin E succinate polymer for precise cancer therapy. Int J Nanomed. 2020;15:2885–2902.
   PubMed Web of Science ®Google Scholar
• Sharma G, Thakur B, Naushad M, et al. Applications of nanocomposite hydrogels for biomedical engineering and environmental protection. Environ Chem Lett. 2018;16(1):113–146.
   Web of Science ®Google Scholar
• Wang Y, Deng M, Chen Q, et al. Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the ras pathway. Eur J Pharmacol. 2019;843:145–153.
   PubMed Web of Science ®Google Scholar
• Chen X, Tang LJ, Sun YN, et al. Syntheses, characterization and antitumor activities of transition metal complexes with isoflavone. J Inorg Biochem. 2010;104(4):379–384.
   PubMed Web of Science ®Google Scholar